Tirzepatide 60mg
Out of StockSKU: TR60
This item is currently unavailable.
£167.00
Research overview
Tirzepatide is a synthetic peptide that acts as a dual agonist at the GIP and GLP-1 receptors, developed initially as an investigational compound for metabolic research.
In qualified laboratories it is employed in receptor-binding assays, cAMP signalling studies, and bioanalytical method validation. It is supplied as a research reagent only and is not intended for clinical or personal use.
Scientific identity
- Designation
- Tirzepatide
- Class
- Dual GIP / GLP-1 receptor agonist (research compound)
- Form
- Lyophilised powder
Areas of laboratory research
- GIP and GLP-1 receptor pharmacology
- Incretin signalling in cell-based assays
- Peptide stability and formulation research
- Quantitative bioanalysis (LC-MS/MS)
Vial contents & storage
Contents: One lyophilised research vial (60 mg), supplied for individual laboratory use.
Storage: Lyophilised material: store at ≤-20°C. If reconstituted, store at 2–8°C.
Supplied strictly for in vitro laboratory research. Not for human or veterinary administration, diagnosis, or therapeutic use.
Research Use Only: All products sold by UK Sterling Peptides are intended exclusively for in vitro laboratory research. They are not for human or veterinary use, diagnosis, treatment, or consumption. Buyers are responsible for compliance with all applicable UK laws and regulations.